Dipeptides from Lactiplantibacillus plantarum limit Pseudomonas aeruginosa pathogenesis
Journal of Applied Microbiology · 2024
DOI: 10.1093/jambio/lxae285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Jayanth Narasimulu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603203, Chengalpattu District, Tamil N…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Biofilms, Dipeptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Aims
Lactobacilli have drawn a great deal of attention due to the heterogeneity of their cells, as well as their remarkable ability to adapt to a range of harsh conditions. One such adaptation response by Lactiplantibacillus plantarum was forming a V-shaped cell structure in low acidic pH conditions. This study aims to identify low pH induced-biofilm formation in L. plantarum and Limosilactobacillus reuteri and their antagonistic interactions with an opportunistic pathogen, Pseudomonas aeruginosa PAO1. Methods and results Dual species bacterial interactions revealed a Lactobacilli biofilm-mediated suppression of PAO1 biofilms and pyocyanin pigment. Furthermore, filtrates from Lactobacilli grown at low acidic pH (pH 3.5) effectively arrest the pathogenesis of P. aeruginosa PAO1, including biofilm, swarming motility, and pyocyanin formation. Liquid chromatography-mass spectroscopy analysis revealed the presence of several Lactobacilli-secreted metabolites and dipeptides that exhibited strong LasR receptor antagonistic interactions in molecular docking analysis. Prolyl-tyrosine showed the best lasR antagonistic and PAO1 biofilm inhibitory activities of the identified dipeptides.
Conclusion
Overall, the results will contribute to the development of anti-infective drugs against P. aeruginosa using Lactobacilli secreted dipeptides. Furthermore, the investigation identifies several dipeptides that can be extracted from V-shaped Lactobacilli for antimicrobial protein therapy against P. aeruginosa and other pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603203, Chengalpattu District, Tamil Nadu, India.
- School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea.
- Center for Drug Discovery and Development (CD3), Amity Institute of Biotechnology, Amity University Maharashtra, Bhatan, Panvel, Mumbai, Maharashtra 410206, India.
Zitieren
APA
Narasimulu, J., Baburajan, N., Saravanan, T. S., Raorane, C. J., Vaidyanathan, V. K., Ravichandran, V., & Rajasekharan, S. K. (2024). Dipeptides from Lactiplantibacillus plantarum limit Pseudomonas aeruginosa pathogenesis. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae285
Vancouver
Narasimulu J, Baburajan N, Saravanan TS, Raorane CJ, Vaidyanathan VK, Ravichandran V, et al. Dipeptides from Lactiplantibacillus plantarum limit Pseudomonas aeruginosa pathogenesis. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae285
BibTeX
@article{Narasimulu2024,
author = {Narasimulu, Jayanth and Baburajan, Nandana and Saravanan, Tamil Selvam and Raorane, Chaitany Jayprakash and Vaidyanathan, Vinoth Kumar and Ravichandran, Vinothkannan and Rajasekharan, Satish Kumar},
title = {Dipeptides from Lactiplantibacillus plantarum limit Pseudomonas aeruginosa pathogenesis},
journal = {Journal of Applied Microbiology},
year = {2024},
doi = {10.1093/jambio/lxae285}
}
EUVIMED